Epiodyne Revenue and Competitors
Estimated Revenue & Valuation
- Epiodyne's estimated annual revenue is currently $620k per year.
- Epiodyne's estimated revenue per employee is $155,000
Employee Data
- Epiodyne has 4 Employees.
- Epiodyne grew their employee count by 0% last year.
Epiodyne's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Research & Development | Reveal Email/Phone |
Epiodyne Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Epiodyne?
Epiodyne was founded to develop breakthrough small molecule medicines based upon novel insights into GPCR receptor pharmacology that were uncovered by leading researchers at UCSF, Stanford and Duke. Together with our founders and with the highly experienced medicinal chemistry team at R2M Pharma (https://www.linkedin.com/company/r2m-pharma/), we are using quantitative pharmacological and behavioral techniques to translate our insights into novel medicines for patients with opioid use disorder (OUD). We are backed by a syndicate of experienced biotech VCs and located in the Bay Area.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 4 | -33% | $18M |
#2 | $0.1M | 4 | -20% | $47.5M |
#3 | $0.1M | 4 | 0% | $15M |
#4 | $0.1M | 4 | -20% | $34.3M |
#5 | $0.3M | 4 | N/A | N/A |